PRODUCT LITERATURE

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

---

The RESTORE study, a multi-national randomized, placebo-controlled study, showed that erdosteine – a muco-active antioxidant that modulates bacterial adhesiveness – reduced the rate and duration of exacerbations in moderate and severe COPD with a history
of exacerbations. How much benefit patients with less severe disease experience when taking this drug remains unclear

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Erdosteine
COPD
The RESTORE study

Specific Detail Info

International Journal of Chronic Obstructive Pulmonary Disease 2019:14 2733–2744

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment